Company performance
Add to research
Current Price
as of Mar 12, 2025$31.81
P/E Ratio
N/A
Market Cap
$1.88B
Loading...
Description
Add to research
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerJANX
- Price$31.81+8.75%
Trading Information
- Market cap$1.88B
- Float83.21%
- Average Daily Volume (1m)952,619
- Average Daily Volume (3m)981,535
- EPS-$1.28
Company
- Revenue$10.59M
- Rev growth (1yr)30.99%
- Net income-$68.99M
- Gross margin80.54%
- EBITDA margin-914.12%
- EBITDA-$96.79M
- EV$1.88B
- EV/Revenue177.15
- P/EN/A
- P/S161.49
- P/B1.84
- Debt/Equity2.25
Documents
Add to research
SEC Filings